Tengjun Biotechnology Corp Stock Net Income
| TJBHDelisted Stock | USD 2.00 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Tengjun Biotechnology's long-term financial health and intrinsic value.
Tengjun |
Tengjun Biotechnology Corp OTC Stock Net Income Analysis
Tengjun Biotechnology's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Tengjun Biotechnology Net Income | (747.52 K) |
Most of Tengjun Biotechnology's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tengjun Biotechnology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Tengjun Biotechnology Corp reported net income of (747,525). This is 100.07% lower than that of the Consumer Defensive sector and 99.24% lower than that of the Packaged Foods industry. The net income for all United States stocks is 100.13% higher than that of the company.
Tengjun Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tengjun Biotechnology's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tengjun Biotechnology could also be used in its relative valuation, which is a method of valuing Tengjun Biotechnology by comparing valuation metrics of similar companies.Tengjun Biotechnology is currently under evaluation in net income category among its peers.
Tengjun Fundamentals
| Return On Equity | 2.01 | |||
| Return On Asset | 0.34 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 385.53 M | |||
| Shares Outstanding | 96.31 M | |||
| Shares Owned By Insiders | 53.02 % | |||
| Price To Book | 50.08 X | |||
| Price To Sales | 4.19 X | |||
| EBITDA | (424.11 K) | |||
| Net Income | (747.52 K) | |||
| Cash And Equivalents | 6.76 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 301.43 K | |||
| Current Ratio | 0.70 X | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (561.3 K) | |||
| Earnings Per Share | 0.09 X | |||
| Number Of Employees | 19 | |||
| Beta | 2.53 | |||
| Market Capitalization | 595.19 M | |||
| Total Asset | 14.03 M | |||
| Net Asset | 14.03 M |
About Tengjun Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tengjun Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tengjun Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tengjun Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Tengjun Biotechnology information on this page should be used as a complementary analysis to other Tengjun Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Tengjun OTC Stock
If you are still planning to invest in Tengjun Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tengjun Biotechnology's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |